QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 限定条件 发表日期：2022    专题：合肥物质科学研究院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Safety and Efficacy of D-1553 in Patients with KRAS G12C Mutated Non-Small Cell Lung Cancer: A Phase 1 Trial 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17 作者:  Lu, S.;  Jian, H.;  Zhang, Y.;  Song, Z.;  Zhao, Y. 收藏  |  浏览/下载：21/0  |  提交时间：2022/12/23 Non-small cell lung cancer  KRAS G12C mutation  Small molecular inhibitor   Sugemalimab vs Placebo after cCRT or sCRT in pts with Unresectable Stage III NSCLC: Final PFS Analysis of a Phase 3 Study 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17 作者:  Wu, Y. -L.;  Zhou, Q.;  Chen, M.;  Pan, Y.;  Jian, O. 收藏  |  浏览/下载：22/0  |  提交时间：2022/12/23 CCRT  sCRT  PD-L1 inhibitor   DIII-D research advancing the physics basis for optimizing the tokamak approach to fusion energy 期刊论文 NUCLEAR FUSION, 2022, 卷号: 62 作者:  Fenstermacher, M. E.;  Abbate, J.;  Abe, S.;  Abrams, T.;  Adams, M. 收藏  |  浏览/下载：38/0  |  提交时间：2022/12/23 DIII-D  tokamak  fusion energy  plasma physics  core-edge integration   Status and associated factors of cross-regional healthcare-seeking among patients with advanced colorectal cancer in China: a multicenter cross-sectional study 期刊论文 ANNALS OF TRANSLATIONAL MEDICINE, 2022 作者:  Zhang, Jian-Gong;  Wang, Hong;  Gu, Xiao-Fen;  Wang, Xiao-Yang;  Wang, Wen-Jun 收藏  |  浏览/下载：36/0  |  提交时间：2022/05/16 Colorectal cancer (CRC)  cross-regional healthcare-seeking  cross-sectional study   The choice of medical facility and associated factors among Chinese advanced colorectal cancer patients: a cross-sectional multi-center study 期刊论文 ANNALS OF TRANSLATIONAL MEDICINE, 2022 作者:  Wang, Xiao-Yang;  Wang, Wen-Jun;  Zhao, Yu-Qian;  Liu, Yin;  Wang, Xiao-Hui 收藏  |  浏览/下载：31/0  |  提交时间：2022/05/16 Colorectal cancer (CRC)  healthcare seeking  medical facility  associated factors   Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial 期刊论文 LANCET ONCOLOGY, 2022, 卷号: 23 作者:  Zhou, Qing;  Chen, Ming;  Jiang, Ou;  Pan, Yi;  Hu, Desheng 收藏  |  浏览/下载：104/0  |  提交时间：2022/03/21